2BB score and signals
ARS Pharmaceuticals, Inc.’s current 2BB score is 51 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 66 | High |
| Momentum | 61 | Improving |
| Financial strength | 24 | Weak |
| Quality | 99 | Very Strong |
| Risk | 68 | High |
2BBBullish & Bearish
ARS Pharmaceuticals, Inc. (SPRY) trades on NASDAQ. It operates in the Health Care sector, Biotechnology industry. Its current 2BB score is 51 out of 100.
ARS Pharmaceuticals, Inc.’s current 2BB score is 51 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 66 | High |
| Momentum | 61 | Improving |
| Financial strength | 24 | Weak |
| Quality | 99 | Very Strong |
| Risk | 68 | High |
| Founded | 2015 |
| Employees | 198 |
| 52-week range | $3.88 – $13.15 |
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|---|---|---|---|
| 2027-03-08 | — | -0.306 | — | $31.33M |
| 2026-11-09 | — | -0.3188 | — | $43.70M |
| 2026-08-13 | — | -0.5024 | — | $31.95M |
| 2026-05-15 | -0.61 | -0.536 | $22.68M | $22.67M |